(Q83904901)
Statements
First-line bevacizumab-containing therapy for triple-negative breast cancer: analysis of 585 patients treated in the ATHENA study (English)
Christoph Thomssen
Jean-Yves Pierga
Kathleen I Pritchard
Hernan Cortes-Funes
Katarína Petráková
Bella Kaufman
Anja Duenne